Dermatology Reports最新文献

筛选
英文 中文
The suitability of mesenchymal stem cells for treating immune-mediated inflammatory skin diseases: a systematic review. 间充质干细胞治疗免疫介导的炎症性皮肤病的适用性:系统综述
IF 2.3
Dermatology Reports Pub Date : 2025-07-01 DOI: 10.4081/dr.2025.10112
Elena Pezzolo, Sara Di Leo, Paola Miceli, Alvise Sernicola, Luigi Naldi
{"title":"The suitability of mesenchymal stem cells for treating immune-mediated inflammatory skin diseases: a systematic review.","authors":"Elena Pezzolo, Sara Di Leo, Paola Miceli, Alvise Sernicola, Luigi Naldi","doi":"10.4081/dr.2025.10112","DOIUrl":"https://doi.org/10.4081/dr.2025.10112","url":null,"abstract":"<p><p>Mesenchymal stem cell (MSC) therapy holds promise for treating immune-mediated inflammatory skin diseases (IMIDs), particularly when conventional therapies are ineffective. Encouraged by their immunomodulatory capabilities and potential for disease modification, different clinical trials are investigating the efficacy and safety of MSCs in single IMIDs. This review aims to summarize the application of MSCs in IMIDs and explore their future clinical potential. We reviewed published studies from January 2016 to January 2024 on MSC treatment for IMIDs. We retrieved 18 clinical trials and 5 observational studies, encompassing 609 patients with psoriasis, atopic dermatitis (AD), chronic spontaneous urticaria (CSU), alopecia areata (AA), systemic sclerosis (SSc), and systemic lupus erythematosus (SLE). Improvements or complete remission were observed in up to 100% of cases for AA, SSc, and SLE, though complete remission rates were less frequent than improvement rates, ranging from 0% in AD to 50% in CSU. Adverse events (AEs) were generally mild; moderate-to-severe AEs were uncommon (4% in psoriasis, 2.6% in SLE, and 0.7% in SSc), and deaths from all causes were rare (6 patients with SSc and 15 patients with SLE). In conclusion, MSC therapy shows promising results in terms of at least partial clinical improvement for most IMIDs. Its effect is achievable after a single or a few administrations, with no significant toxicity. MSCs may fulfill an unmet need for patients unresponsive to conventional immunomodulating agents. However, most evidence still comes from clinical trials with heterogeneous designs and endpoints. Future larger controlled trials are needed to better elucidate their role in refractory IMIDs.</p>","PeriodicalId":11049,"journal":{"name":"Dermatology Reports","volume":" ","pages":""},"PeriodicalIF":2.3,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144539407","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Efficacy and safety of adalimumab biosimilar GP2017 in a 24-month treatment period for plaque psoriasis: real-life experience from Emilia-Romagna centers, Italy. 阿达木单抗生物仿制药GP2017在斑块型银屑病24个月治疗期的疗效和安全性:来自意大利艾米利亚-罗马涅中心的真实经验
IF 2.3
Dermatology Reports Pub Date : 2025-07-01 DOI: 10.4081/dr.2025.10315
Marco May Lee, Vito Di Lernia, Francesca Peccerillo, Federico Bardazzi, Michela Tabanelli, Michela Ricci, Davide Melandri, Monica Corazza, Francesca Satolli, Andrea Conti
{"title":"Efficacy and safety of adalimumab biosimilar GP2017 in a 24-month treatment period for plaque psoriasis: real-life experience from Emilia-Romagna centers, Italy.","authors":"Marco May Lee, Vito Di Lernia, Francesca Peccerillo, Federico Bardazzi, Michela Tabanelli, Michela Ricci, Davide Melandri, Monica Corazza, Francesca Satolli, Andrea Conti","doi":"10.4081/dr.2025.10315","DOIUrl":"https://doi.org/10.4081/dr.2025.10315","url":null,"abstract":"<p><p>Adalimumab (ADA), a monoclonal antibody targeting TNF-α, is effective in treating moderate to severe psoriasis. The emergence of biosimilars, such as GP2017 (Hyrimoz®), has raised concerns about their safety and efficacy compared to the originator. This two-year observational study evaluated the effectiveness and safety of GP2017 in 171 patients from Emilia-Romagna, Italy. Patients were divided into two groups: 78 transitioned from the ADA originator, and 93 were biologic-naive. Changes in the Psoriasis Area and Severity Index (PASI) were analyzed. In the switch group, PASI scores remained stable, while the naive group achieved significant improvements (PASI 75: 52% at 3 months, 89% at 6 months). Adverse events leading to discontinuation were rare. The findings confirm that GP2017 is as effective and safe as the ADA originator, supporting its use as a cost-effective alternative in the treatment of psoriasis. Biosimilars play a crucial role in promoting equitable access to biologic therapies.</p>","PeriodicalId":11049,"journal":{"name":"Dermatology Reports","volume":" ","pages":""},"PeriodicalIF":2.3,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144539405","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Durable complete response in a patient with BRAF-mutated advanced melanoma with ocular and skin toxicities from BRAF/MEK targeted therapy after immune checkpoint inhibitor treatment: a case report. 免疫检查点抑制剂治疗后BRAF突变晚期黑色素瘤伴眼部和皮肤毒性的持久完全缓解:1例报告
IF 2.3
Dermatology Reports Pub Date : 2025-06-17 DOI: 10.4081/dr.2025.10324
Carlotta Bertolina, Marinella Bertolotti, Claudia Leporati, Antonina Maria De Angelis, Sara Delfanti, Luigi Cerbone, Marco Ghiglione, Federica Grosso
{"title":"Durable complete response in a patient with BRAF-mutated advanced melanoma with ocular and skin toxicities from BRAF/MEK targeted therapy after immune checkpoint inhibitor treatment: a case report.","authors":"Carlotta Bertolina, Marinella Bertolotti, Claudia Leporati, Antonina Maria De Angelis, Sara Delfanti, Luigi Cerbone, Marco Ghiglione, Federica Grosso","doi":"10.4081/dr.2025.10324","DOIUrl":"https://doi.org/10.4081/dr.2025.10324","url":null,"abstract":"<p><p>Here we report the case of a woman suffering from advanced melanoma who developed severe toxicities with BRAF and MEK inhibitors (BRAFis, MEKis), given as second-line therapy after failure of immunotherapy, who achieved a complete and durable response lasting for over 5 years. Significant progress has been achieved in the treatment of advanced melanoma with immune checkpoint inhibitors (ICIs) and targeted therapies using BRAFis and MEKis. While these treatments improve survival, they also pose risks of severe toxicities. Notably, when targeted therapy follows immunotherapy, immune-mediated toxicities may emerge months later due to tumor microenvironment modulation. Despite these risks, both approaches offer a durable response in eligible patients. Further understanding is needed to determine how prior immunotherapy may influence subsequent toxicity risks of target therapy. Understanding these factors could optimize treatment strategies and improve patient outcomes.</p>","PeriodicalId":11049,"journal":{"name":"Dermatology Reports","volume":" ","pages":""},"PeriodicalIF":2.3,"publicationDate":"2025-06-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144316153","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Post-COVID-19 resurgence of scabies in Campania, Italy: the hidden burden and challenges in surveillance. 意大利坎帕尼亚地区2019冠状病毒病后疥疮卷土重来:监测工作中的隐性负担和挑战
IF 2.3
Dermatology Reports Pub Date : 2025-06-13 DOI: 10.4081/dr.2025.10409
Caterina Mariarosaria Giorgio, Gaetano Licata, Maria Maddalena Nicoletti, Eugenia Veronica Di Brizzi, Vittorio Tancredi, Giuseppe Argenziano, Valentina Cozza, Adone Baroni
{"title":"Post-COVID-19 resurgence of scabies in Campania, Italy: the hidden burden and challenges in surveillance.","authors":"Caterina Mariarosaria Giorgio, Gaetano Licata, Maria Maddalena Nicoletti, Eugenia Veronica Di Brizzi, Vittorio Tancredi, Giuseppe Argenziano, Valentina Cozza, Adone Baroni","doi":"10.4081/dr.2025.10409","DOIUrl":"https://doi.org/10.4081/dr.2025.10409","url":null,"abstract":"<p><p>Scabies, a contagious parasitic skin disease caused by Sarcoptes scabiei, has shown a marked resurgence in several European regions following the COVID-19 pandemic. In Campania, Italy, reported cases increased from 42 in 2020 to 748 in 2024, according to the regional surveillance system (Sistema Premal-UOD). However, the true burden of disease is likely underestimated due to widespread underreporting, delayed diagnosis, and a hidden reservoir of undetected or self-treated cases. This study analyzes epidemiological trends in Campania, highlights limitations in surveillance, and examines the role of pseudo-resistance in treatment failures. The findings underscore the need for robust monitoring, accurate diagnostics, and public health interventions to reduce the ongoing spread of scabies in the region.</p>","PeriodicalId":11049,"journal":{"name":"Dermatology Reports","volume":" ","pages":""},"PeriodicalIF":2.3,"publicationDate":"2025-06-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144301312","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Keratosis lichenoides chronica: a case report with dermatoscopic and ultrasonographic analysis. 慢性地衣角化病1例并皮镜及超声分析。
IF 2.3
Dermatology Reports Pub Date : 2025-06-11 DOI: 10.4081/dr.2025.10093
Katarzyna Korecka, Monika Bowszyc-Dmochowska, Nina Łabędź, Ryszard Żaba, Aleksandra Dańczak-Pazdrowska, Adriana Polańska
{"title":"Keratosis lichenoides chronica: a case report with dermatoscopic and ultrasonographic analysis.","authors":"Katarzyna Korecka, Monika Bowszyc-Dmochowska, Nina Łabędź, Ryszard Żaba, Aleksandra Dańczak-Pazdrowska, Adriana Polańska","doi":"10.4081/dr.2025.10093","DOIUrl":"https://doi.org/10.4081/dr.2025.10093","url":null,"abstract":"<p><p>We present the case of a 46-year-old woman with a long-standing history of linear erythematosquamous papules on the arms and thighs, which were unresponsive to treatment with topical corticosteroids. She also reported lesions typical of seborrheic dermatitis located on her face. After performing a clinical examination, dermatoscopy, high-frequency ultrasonography (HFUS), and a biopsy for histopathological examination, a diagnosis of keratosis lichenoides chronica (KLC) was obtained. Also known as Nekam disease, keratosis lichenoides chronica is a rare, chronic inflammatory skin disease characterized by diffuse, linearly arranged erythro- or erythematosquamous papules with a thin, keratotic plug.</p>","PeriodicalId":11049,"journal":{"name":"Dermatology Reports","volume":" ","pages":""},"PeriodicalIF":2.3,"publicationDate":"2025-06-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144274393","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Anamnestic, clinical, and dermoscopic predictors of malignancy in melanocytic lesions with peripheral globules: a retrospective study. 外周小球黑素细胞病变中恶性肿瘤的记忆、临床和皮肤镜预测因素:一项回顾性研究。
IF 2.3
Dermatology Reports Pub Date : 2025-06-10 DOI: 10.4081/dr.2025.10334
Enrico Zelin, Vanessa Mazzoletti, Jessica Paladin, Andrea Corio, Raffaele Dante Caposiena Caro, Giulia Bazzacco, Enzo Errichetti, Nicola Di Meo, Iris Zalaudek
{"title":"Anamnestic, clinical, and dermoscopic predictors of malignancy in melanocytic lesions with peripheral globules: a retrospective study.","authors":"Enrico Zelin, Vanessa Mazzoletti, Jessica Paladin, Andrea Corio, Raffaele Dante Caposiena Caro, Giulia Bazzacco, Enzo Errichetti, Nicola Di Meo, Iris Zalaudek","doi":"10.4081/dr.2025.10334","DOIUrl":"https://doi.org/10.4081/dr.2025.10334","url":null,"abstract":"<p><p>Melanocytic lesions with peripheral globules (MLPGs) usually represent lesions in an active growth phase and should be carefully evaluated in adults and the elderly, since melanoma can rarely present with this pattern. The primary aim of this study was to identify anamnestic, clinical, and dermoscopic features associated with malignancy (histologic outcome of melanoma) in MLPGs. The secondary aim was to describe the frequency of these features. We conducted a retrospective cross-sectional observational study, evaluating anamnestic, clinical, and dermoscopic features of MLPGs excised at the Dermatology Clinic of Trieste, Italy (January 2019-June 2023). The association between each variable and the histologic outcome (nevus or melanoma) was assessed using Fisher's exact test. Differences in age and lesion diameter distribution between nevi and melanomas were analyzed using Student's t-test for independent variables. Several lesion characteristics were associated with malignancy, including a personal history of melanoma (p=0.0069), localization on the lower limbs (p=0.0215), and lesion diameter ≥6 mm (p=0.0025). Several dermoscopic features were also associated with malignancy, namely non-circumferential peripheral globules (p=0.0406), regression (p=0.0042), evident vascular pattern/pink areas (p=0.0007), inverse network (p=0.0243), and asymmetric central globules (p=0.0057). Additionally, the comparison between melanoma and nevi groups confirmed that malignant lesions were characterized by a higher mean age at diagnosis (p=0.0237) and a larger mean diameter (p=0.000112). This study provides practical guidance for the management of MLPGs, highlighting that several anamnestic, clinical, and dermoscopic features are suggestive of malignancy.</p>","PeriodicalId":11049,"journal":{"name":"Dermatology Reports","volume":" ","pages":""},"PeriodicalIF":2.3,"publicationDate":"2025-06-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144265546","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Linear psoriasis or ILVEN? A pediatric case unraveling the mosaic puzzle. 直线型银屑病还是ILVEN?一个儿科病例解开了拼图。
IF 2.3
Dermatology Reports Pub Date : 2025-06-06 DOI: 10.4081/dr.2025.10429
Nicolò Rivetti, Camilla Vassallo, Stefania Barruscotti, Valeria Brazzelli, Carlo Francesco Tomasini
{"title":"Linear psoriasis or ILVEN? A pediatric case unraveling the mosaic puzzle.","authors":"Nicolò Rivetti, Camilla Vassallo, Stefania Barruscotti, Valeria Brazzelli, Carlo Francesco Tomasini","doi":"10.4081/dr.2025.10429","DOIUrl":"https://doi.org/10.4081/dr.2025.10429","url":null,"abstract":"<p><p>Linear psoriasiform eruptions in children are diagnostically challenging, particularly when they follow Blaschko's lines. The main differential diagnosis includes inflammatory linear verrucous epidermal nevus (ILVEN) and linear psoriasis (LP), a rare mosaic variant. We describe the case of a 5-year-old boy with extensive unilateral lesions clinically suggestive of both entities. Histology revealed Munro microabscesses and psoriasiform hyperplasia. The patient showed rapid improvement with topical calcipotriol/betamethasone, followed by long-term remission. Notably, after 8 years of follow-up, the lesions remained strictly confined to the original Blaschkoid distribution, with no extracutaneous involvement and only mild recurrences. This clinical course strongly supports the diagnosis of isolated linear psoriasis (type 1 mosaicism). Few pediatric cases in the literature have documented such a long and stable evolution, making this report a valuable contribution to the distinction between LP and ILVEN. The case highlights the importance of integrating clinical, histological, and longitudinal data when evaluating linear dermatoses in children.</p>","PeriodicalId":11049,"journal":{"name":"Dermatology Reports","volume":" ","pages":""},"PeriodicalIF":2.3,"publicationDate":"2025-06-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144257552","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Severe paradoxical generalized pustular psoriasis induced by adalimumab biosimilar successfully treated with brodalumab. 博达鲁单抗成功治疗阿达木单抗生物仿制药诱导的严重异位广泛性脓疱性银屑病。
IF 2.3
Dermatology Reports Pub Date : 2025-05-30 DOI: 10.4081/dr.2025.10414
Angela Fico, Edoardo Mortato, Claudia Paganini, Marina Talamonti, Cosimo Di Raimondo, Dionisio Silvaggio, Luca Bianchi, Marco Galluzzo
{"title":"Severe paradoxical generalized pustular psoriasis induced by adalimumab biosimilar successfully treated with brodalumab.","authors":"Angela Fico, Edoardo Mortato, Claudia Paganini, Marina Talamonti, Cosimo Di Raimondo, Dionisio Silvaggio, Luca Bianchi, Marco Galluzzo","doi":"10.4081/dr.2025.10414","DOIUrl":"https://doi.org/10.4081/dr.2025.10414","url":null,"abstract":"<p><p>Paradoxical psoriasis is a rare but increasingly recognized adverse effect of anti-TNF-α therapy, characterized by the onset or exacerbation of psoriatic lesions in patients treated for other immune-mediated conditions. We report the case of a 47-year-old woman with chronic plaque psoriasis who developed severe generalized pustular psoriasis (GPP) after six months of treatment with an adalimumab biosimilar. Given the extent and severity of the eruption and following inadequate response to previous conventional therapies, the patient was treated with brodalumab, an IL-17RA inhibitor. Rapid and complete remission of both pustular and plaque psoriasis was achieved and maintained for over 60 weeks. This case supports the efficacy of IL-17 pathway blockade in managing paradoxical GPP and highlights the importance of prompt recognition and appropriate therapeutic switching in severe biologic-induced psoriasis.</p>","PeriodicalId":11049,"journal":{"name":"Dermatology Reports","volume":" ","pages":""},"PeriodicalIF":2.3,"publicationDate":"2025-05-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144207954","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Autosomal recessive woolly hair/hypotrichosis with homozygous mutation in the LIPH gene: a case report. 常染色体隐性羊毛/毛少症与LIPH基因纯合突变:1例报告。
IF 2.3
Dermatology Reports Pub Date : 2025-05-29 DOI: 10.4081/dr.2025.10177
Khalid Alwunais, Jamal Alqahtani, Abdullah Ali N Aljalfan, Hadeel Alotaibi
{"title":"Autosomal recessive woolly hair/hypotrichosis with homozygous mutation in the <i>LIPH</i> gene: a case report.","authors":"Khalid Alwunais, Jamal Alqahtani, Abdullah Ali N Aljalfan, Hadeel Alotaibi","doi":"10.4081/dr.2025.10177","DOIUrl":"https://doi.org/10.4081/dr.2025.10177","url":null,"abstract":"<p><p>Autosomal recessive woolly hair/hypotrichosis (ARWH/H) is a hereditary hair disorder characterized by sparse, short, and curly hair. Mutations in the Lipase H (LIPH) gene, LPAR6, or other genes cause this hereditary hair condition. We report a case of an 11-month-old Saudi boy who presented to our dermatology clinic at King Fahad University Hospital in Al-Khobar (Saudi Arabia) with short, non-growing hair since birth. DNA sequencing revealed a homozygous mutation in the LIPH gene at c.280_369dup. Our patient was diagnosed with ARWH/H resulting from a homozygous mutation in LIPH.</p>","PeriodicalId":11049,"journal":{"name":"Dermatology Reports","volume":" ","pages":""},"PeriodicalIF":2.3,"publicationDate":"2025-05-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144207952","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
S-MAPA: bridging the gap in psoriasis severity assessment. S-MAPA:弥合银屑病严重程度评估的差距。
IF 2.3
Dermatology Reports Pub Date : 2025-05-28 DOI: 10.4081/dr.2025.10231
Trang Thi Thuy Vu, Chuyen Thi Hong Nguyen, Trung The Van
{"title":"S-MAPA: bridging the gap in psoriasis severity assessment.","authors":"Trang Thi Thuy Vu, Chuyen Thi Hong Nguyen, Trung The Van","doi":"10.4081/dr.2025.10231","DOIUrl":"https://doi.org/10.4081/dr.2025.10231","url":null,"abstract":"<p><p>The Psoriasis Area and Severity Index (PASI) is widely used to evaluate psoriatic disease activity in clinical settings; however, its limitations hinder its practicality in routine use. The Simple-Measure for Assessing Psoriasis Severity (S-MAPA) has emerged as a promising tool addressing these limitations, providing a more feasible approach for assessing disease severity. This study aimed to evaluate the S-MAPA as a sensitive and practical alternative to existing instruments for measuring psoriasis severity. Patients with psoriasis were assessed using body surface area (BSA), the Physician's Global Assessment (PGA), S-MAPA, PASI, and Dermatology Life Quality Index (DLQI). Plasma high-sensitivity C-reactive protein (hs-CRP) levels were also measured. Spearman's correlation analysis compared the relationships between these assessment tools and hs-CRP levels. In total, 100 assessments were conducted between January and July 2019. The S-MAPA score and PASI showed a strong positive correlation with disease severity (r=0.9315, p<0.01). Both the S-MAPA score and PASI exhibited comparable correlations with hs-CRP levels (r=0.5299 vs. 0.5316) and the DLQI (r=0.2533 vs. 0.2641). The S-MAPA score demonstrated stronger correlations with the PASI, DLQI, and hs-CRP level than with BSA or the PGA score. The area under the receiver operating characteristic curve for the S-MAPA was 0.9787, with an optimal cut-off value of 138 for predicting severe psoriasis (sensitivity, 92.59%; specificity, 95.89%). Based on our findings, the S-MAPA is a reliable and practical alternative for assessing the severity of psoriasis in clinical practice, offering advantages over conventional measures.</p>","PeriodicalId":11049,"journal":{"name":"Dermatology Reports","volume":" ","pages":""},"PeriodicalIF":2.3,"publicationDate":"2025-05-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144157243","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信